Psychemedics Corp.  

(Public, NASDAQ:PMD)   Watch this stock  
Find more results for PMD
11.06
Aug 31 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 9.82 - 17.83
Open     -
Vol / Avg. 0.00/17,732.00
Mkt cap 60.19M
P/E 28.09
Div/yield 0.15/5.42
EPS 0.39
Shares 5.42M
Beta 1.01
Inst. own 56%
Oct 28, 2015
Q3 2015 Psychemedics Corp Earnings Release (Estimated) Add to calendar
Jul 28, 2015
Q2 2015 Psychemedics Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 3.60% 10.98%
Operating margin 5.09% 16.06%
EBITD margin - 19.65%
Return on average assets 4.43% 15.78%
Return on average equity 8.26% 25.53%
Employees 156 -
CDP Score - -

Address

Suite 200, 125 Nagog Park
ACTON, MA 01720
United States - Map
+1-800-6288073 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Psychemedics Corporation (Psychemedics) provides testing services for the detection of drugs of abuse through the analysis of hair samples. The Company’s testing methods utilize a technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company’s primary application of its technology is as a testing service that analyzes hair samples for the presence of certain drugs of abuse. The Company performs a custom-designed enzyme immunoassay (EIA) on the liquid supernatant, with confirmation testing by mass spectrometry. Psychemedics provides screening and confirmation by mass spectrometry using various practices for cocaine, marijuana, phencyclidine (PCP), amphetamines, including ecstasy, and opiates, including heroin, hydrocodone, hydromorphone, oxycodone and codeine. The Company also offers a test for alcohol using hair, which measures average alcohol consumption over a period of approximately three months.

Officers and directors

Raymond C Kubacki Jr. Chairman of the Board, President, Chief Executive Officer
Age: 70
Bio & Compensation  - Reuters
Neil L. Lerner Vice President - Finance
Age: 47
Bio & Compensation  - Reuters
Michael I. Schaffer Ph.D. Vice President - Laboratory Operations
Age: 70
Bio & Compensation  - Reuters
James V. Dyke Corporate Vice President - Sales and Marketing
Age: 50
Bio & Compensation  - Reuters
Harry F. Connick Sr. Independent Director
Age: 89
Bio & Compensation  - Reuters
Walter S. Tomenson Jr. Independent Director
Age: 68
Bio & Compensation  - Reuters
Fred J. Weinert Independent Director
Age: 67
Bio & Compensation  - Reuters